Lv1
10 积分 2024-08-20 加入
Brief Report: EGFR L833V/H835L Duplex-Mutated NSCLC With Leptomeningeal Carcinomatosis Responsive to Osimertinib
17小时前
待确认
The effectiveness of sequential afatinib and furmonertinib in an advanced lung adenocarcinoma with rare compound EGFR mutation (L833V/H835L)
17小时前
已完结
Stereotactic body radiotherapy with sequential tislelizumab and chemotherapy as neoadjuvant therapy in patients with resectable non-small-cell lung cancer in China (SACTION01): a single-arm, single-centre, phase 2 trial
8天前
已完结
Stereotactic body radiotherapy to the primary lung lesion improves the survival of the selected patients with non-oligometastatic NSCLC harboring EGFR activating mutation with first-line EGFR-TKIs: a real-world study
13天前
已完结
A Multicenter Two-arm, Phase II Trial Assessing the Safety and Efficacy of First-line Lazertinib and Locally Ablative Radiotherapy in Patients With Synchronous Oligo-metastatic EGFR-mutant Non-small Cell Lung Cancer (ABLATE, KCSG-LU21-11)
13天前
已完结
Expression and prognostic analysis of CLDN18 and Claudin18.2 in lung adenocarcinoma
13天前
已完结
Lung Involvement in Destombes-Rosai-Dorfman Disease
15天前
已完结
Cell-intrinsic PD-L1 signaling drives immunosuppression by myeloid-derived suppressor cells through IL-6/Jak/Stat3 in PD-L1-high lung cancer
20天前
已完结
Targeting KRAS Diversity: Covalent Modulation of G12X and Beyond in Cancer Therapy
1个月前
已完结
Targeting KRAS in cancer
1个月前
已完结
皖公网安备34019202002308
